Worldwide Business with kathy Ireland® Highlights New Colonoscopy Scope to Help Detect Colon Cancer Earlier from EndoChoice

Company Leader Will Talk About the Company’s Breakthrough Technology for GI Medical Professionals

Tune into Fox Business Network as sponsored programming on Saturday December 3, 2016 and Bloomberg International on Sunday, December 4, 2016. See market-by-market listings below.

(Los Angeles, CA, November 29, 2016) — Worldwide Business with kathy ireland® announces an exclusive interview with EndoChoice Founder and CEO, Mark Gilreath. The interview will focus on a revolutionary new advancement for colonoscopies.

EndoChoice is a company that focuses on the manufacturing and commercialization of technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists treating a wide range of gastrointestinal conditions, including colon cancer. EndoChoice serves more than 2,500 customers in the United States and works with distribution partners in 30 countries. EndoChoice was founded in 2014 and is headquartered in Detroit, Michigan.

EndoChoice’s latest advancement is Fuse, which is a product that has revolutionized colonoscopies. Gilreath explains more about this breakthrough product, saying, “Fuse is a full spectrum endoscopy. It’s a colonoscope that sees 330 degrees. The traditional colonoscope only sees 170 degrees. Oftentimes, polyps hide behind folds, so the broader field of view is really influential in detecting those polyps that can be killers because they might be pre-cancerous.”

JL Haber, Vice President of Programming for Worldwide Business with kathy ireland®, is thrilled to feature EndoChoice. He says, “Sadly, colon cancer is the second most common killer among cancer patients in America with about 50,000 lives being lost to it every year. However, one good thing about colon cancer is that it’s preventable if the pre-cancerous polyps are found early enough. Thanks to EndoChoice’s revolutionary advancements, polyps are being found sooner, leading to greater survival rates. That’s why we couldn’t be prouder to have EndoChoice on our show.”

For more information about new advancements for colonoscopies from EndoChoice, visit  and tune into Fox Business Network as sponsored programming at 4:30pm EST on Saturday, December 3, 2016 and at 7:00am GMT, 10:00am D.F. and 2:30pm HKT on Sunday, December 4, 2016 on Bloomberg International.

About Worldwide Business with kathy ireland®

Worldwide Business with kathy ireland® is a weekly business television program featuring real-world insights from corporate executives from all over the globe which can be viewed on Fox Business Network as part of their sponsored programming lineup, as well as internationally to over 50 countries on Bloomberg International.

Visit for detailed airing schedules or check your local listings.

Distributed by Worldwide Business with kathy ireland®

Media Contact
Company Name: Worldwide Business with kathy ireland
Contact Person: Gila Stern | Communications Director
Phone: 561-988-8550 x269
Country: United States